
Plushcare Launches Enhanced Online Weight Loss Program To Expand National Access To GLP-1 Prescriptions Through Board-Certified Doctors
San Francisco, June 10, 2025 (GLOBE NEWSWIRE) --
PlushCare, a leading virtual healthcare platform, has announced a significant upgrade to its online Weight Loss Program , enabling greater access to GLP-1-based prescription treatments such as semaglutide through board-certified physicians. This development marks a critical milestone in the company's mission to provide affordable, clinically supervised weight management across the United States.
Accessible at , the updated platform streamlines the process for eligible adults to consult with licensed physicians, receive lab work if necessary, and access customized treatment plans-all from the comfort of their homes.
Expanded Features for 2025
The revamped Weight Loss Program now includes:
- Nationwide Access to medical providers via secure telehealth appointments Eligibility Evaluation for FDA-approved medications, including semaglutide Personalized Plans tailored to each user's metabolic profile Optional Lab Testing with integrated results for precision treatment Transparent Pricing with no insurance required
The platform is optimized for mobile and desktop users, offering a seamless experience from appointment scheduling to prescription delivery.
Addressing a Growing National Health Concern
According to the CDC, over 40% of U.S. adults struggle with obesity, with rising demand for effective clinical support. PlushCare's integrated virtual care model delivers a scalable solution that removes traditional geographic and scheduling barriers.
Patients can typically get started in under 15 minutes by completing an intake form and booking a same-day appointment with a licensed doctor. If clinically appropriate, a prescription is sent to their preferred pharmacy.
About PlushCare
PlushCare is a virtual primary care and mental health platform that connects patients with top U.S. medical professionals through its secure telehealth platform. With a commitment to quality care, convenience, and evidence-based treatment, PlushCare is redefining access to modern healthcare.
For more information, visit .
Media Contact:
PlushCare Media Relations
Email: ...
Website:
Address: 345 California Street, Suite 600, San Francisco, CA 94105, United States
SOURCE: PlushCare
Disclaimer: This release contains forward-looking statements and should not be considered medical advice. All treatments are subject to clinical evaluation and provider discretion.
CONTACT: Email: ...

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Klein Funding And Bybit Partner To Launch A New Era Of Crypto Prop Trading
- B2broker Receives“Best Liquidity Provider” Award At Forex Traders Summit Dubai 2025
- ALT5 Sigma Integrates Lightning Network With Voltage To Enable Instant Bitcoin Payments
- Passport Global Secures U.S. Customs License, Expands Brokerage Across All U.S. Ports
- XDC Network Concludes Integration With Utila Enabling Institutional Access To Custody Assets
- Zircuit Enables Non-Custodial Wallet Top-Ups For Crypto Visa Cards
Comments
No comment